Feed Preview

Fast Growing

Chronic Fatigue Syndrome

Chronic Fatigue Syndrome diagram by Nakatomi et al, Wikimedia
Nakatomi et al, Wikimedia

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Top 20 most recent papers
The Journal of Clinical Investigation

Myalgic encephalomyelitis/chronic fatigue syndrome patients exhibit altered T cell metabolism and cytokine associations

The Journal of Clinical InvestigationDecember 13, 2019
Alexandra H MandaranoMaureen R Hanson
304
5
10
Acta Paediatrica

Myalgic Encephalomyelitis - Time to repent

Acta PaediatricaJanuary 23, 2020
Nigel Speight
16
International Journal of Molecular Sciences

An Isolated Complex V Inefficiency and Dysregulated Mitochondrial Function in Immortalized Lymphocytes from ME/CFS Patients

International Journal of Molecular SciencesFebruary 12, 2020
Daniel MissailidisPaul R Fisher
11
2
BMJ Case Reports

Acute oxalate nephropathy due to high vitamin C doses and exocrine pancreatic insufficiency

BMJ Case ReportsNovember 22, 2019
Lauré Fijen, Marcel Weijmer
28
Fatigue : Biomedicine, Health & Behavior

Myalgic encephalomyelitis and chronic fatigue syndrome case definitions: effects of requiring a substantial reduction in functioning

Fatigue : Biomedicine, Health & BehaviorDecember 4, 2019
Samantha ScartozziLeonard A Jason
3
International Journal of Molecular Sciences

Activation of Transposable Elements in Immune Cells of Fibromyalgia Patients

International Journal of Molecular SciencesFebruary 23, 2020
Tamara OvejeroElisa Oltra
81
4
Journal of Translational Medicine

Reduced heart rate variability predicts fatigue severity in individuals with chronic fatigue syndrome/myalgic encephalomyelitis

Journal of Translational MedicineJanuary 8, 2020
Rosa María EscorihuelaJesús Castro-Marrero
92
9
F1000Research

Understanding neuromuscular disorders in chronic fatigue syndrome

F1000ResearchDecember 10, 2019
Yves Jammes, Frederique Retornaz
34
3
Metabolomics : Official Journal of the Metabolomic Society

A laboratory approach for characterizing chronic fatigue: what does metabolomics tell us?

Metabolomics : Official Journal of the Metabolomic SocietyNovember 29, 2019
Elardus ErasmusCarolus J Reinecke
4
2
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation

Health-related quality of life in patients with myalgic encephalomyelitis/chronic fatigue syndrome: an Australian cross-sectional study

Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and RehabilitationJanuary 24, 2020
N Eaton-FitchSonya Marshall-Gradisnik
49
10
Diagnostics

Biomedical Insights that Inform the Diagnosis of ME/CFS

DiagnosticsFebruary 13, 2020
Brett A Lidbury, Paul R Fisher
33
1

See more papers from this feed

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Antisense Oligonucleotide - Therapies For ALS

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

© 2020 Meta ULC. All rights reserved
/feed-previews/chronic-fatigue-syndrome/68dbfb0f-e560-4919-bf8f-e99721cadd22